Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL1591363 | 0.96 | FFAR3 (0.54) | FFAR3LCKFYNLMNAALDH1A1 | |
| Acetic Acid SCHEMBL1591297 | 0.96 | FFAR3 (0.64) | FFAR3LCKFYNLMNAALDH1A1 | |
| Acetic Acid SCHEMBL694363 | 0.96 | — | — | |
| Acetic Acid SCHEMBL28301301 | 0.96 | FFAR3 (0.64) | FFAR3LCKFYNLMNAALDH1A1 | |
| Acetic Acid SCHEMBL7025787 | 0.93 | FFAR3 (0.50) | FFAR3LCKFYNLMNAALDH1A1 | |
| Acetic Acid SCHEMBL59229 | 0.92 | FFAR3 (0.58) | FFAR3LCKFYNLMNAALDH1A1 | |
| Acetic Acid SCHEMBL8187512 | 0.92 | FFAR3 (0.58) | FFAR3LCKFYNLMNAALDH1A1 | |
| Acetic Acid SCHEMBL8619684 | 0.92 | — | — | |
| Acetic Acid SCHEMBL10906963 | 0.92 | FFAR3 (0.58) | FFAR3LCKFYNLMNAALDH1A1 | |
| Acetic Acid SCHEMBL7097140 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115837063-B | Preparation and detection methods of lung force cough pharmaceutical composition | 贵州健兴药业有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-115837063-A | Preparation and detection method of improved lung-strength cough medicine composition | 贵州健兴药业有限公司 | 2023-03-24 | — | — | CN | disclosed |
| US-20180051304-A1 | Method for Producing DHA-Containing Glyceride-Containing Composition | KEWPIE CORPORATION (JP) | 2018-02-22 | — | — | US | disclosed |
| CN-101787059-B | Method for preparing digalactosyl diacylglycerol and application thereof | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2014-10-15 | — | — | CN | disclosed |
| US-8420646-B2 | Tricyclic tetrahydroquinoline antibacterial agents | PAH P&U LLC (US) | 2013-04-16 | — | — | US | disclosed |
| US-8101655-B2 | Fluorescent dyes and complexes | SMITH GERALD ARTHUR (GB) | 2012-01-24 | — | — | US | disclosed |
| US-20110092494-A1 | Tricyclic Tetrahydroquinoline Antibacterial Agents | PHARMACIA & UPJOHN COMPANY | 2011-04-21 | — | — | US | disclosed |
| US-20100256399-A1 | FLUORESCENT DYES AND COMPLEXES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-10-07 | — | — | US | disclosed |
| CN-101787059-A | Method for preparing digalactosyl diacylglycerol and application thereof | UNIV SHENYANG PHARMACEUTICAL | 2010-07-28 | — | — | CN | disclosed |
| EP-1551849-B1 | TRICYCLIC TETRAHYDROQUINOLINE ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN CO LLC (US) | 2010-07-14 | — | — | EP | disclosed |
| US-4426377-A | BACTERICIDES | BEECHAM GROUP LIMITED (GB) | 1984-01-17 | — | — | US | disclosed |
| US-4372946-A | ENZYME INHIBITORS, BACTERICIDES | BEECHAM GROUP LIMITED (GB) | 1983-02-08 | — | — | US | disclosed |
| EP-0001333-B1 | CLAVULANIC ACID DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1982-09-15 | — | — | EP | disclosed |
| US-4340602-A | CONTRAGESTATIVE AGENT | WAYNE STATE UNIVERSITY (US) | 1982-07-20 | — | — | US | disclosed |
| US-4335121-A | TOPICAL ANTIINFLAMMATORY AGENTS | GLAXO GROUP LIMITED (GB) | 1982-06-15 | — | — | US | disclosed |
| US-4244965-A | B-LACTAMASE INHIBITORS AND BACTERICIDES | BEECHAM GROUP LIMITED (GB) | 1981-01-13 | — | — | US | disclosed |
| US-4215128-A | INHIBITORS OF BETA-LACTAMASE, ANTIBACTERIAL | BEECHAM GROUP LIMITED (GB) | 1980-07-29 | — | — | US | disclosed |
| US-4206120-A | Oxaazabicycloheptane antibiotics | BEECHAM GROUP LIMITED (GB) | 1980-06-03 | — | — | US | disclosed |
| US-4180679-A | HERBICIDES | AMERICAN CYANAMID COMPANY (US) | 1979-12-25 | — | — | US | disclosed |
| EP-0001333-A1 | Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1979-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092494-A1 | Tricyclic Tetrahydroquinoline Antibacterial Agents | QTRT1, QTRT2, NQO2 | FFAR3 3426/4885LCK 4118/4885FYN 4735/4885 |
| US-20100256399-A1 | FLUORESCENT DYES AND COMPLEXES | F12, ANXA6, PYM1 | FFAR3 1126/4885LCK 1668/4885FYN 868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.